Back to Top

EnDevor Scientific successfully completed a Senior Director, Drug Substance search

March, 2017

EnDevor Scientific successfully completed a Senior Director, Drug Substance search. The primary focus is on the drug substance aspects of the clinical phase peptide and small molecule product opportunities. The role interfaces with, and may lead some of, the larger CMC function, and broadly manage across all aspects of preclinical R&D, and across all disease areas of interest. This position will be principally responsible for Drug Substance mid to late stage development including: route optimization and process optimization as well as process scale up, process validation and qualification batches.

Metrics:
5 days after the search was initiated the candidate that was hired for the role was identified and submitted.

11 resumes submitted

33 business days from initiation to acceptance

Client:
Our client is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system.

Search Consultant:
Jed Washburn, Director, Process/Chemical Development/API at EnDevor Scientific, specializes on presenting candidates within drug development to help facilitate company growth, commercialization of products, and to assist with career development. Jed has overseen numerous successful placements ranging from Executive Director to Senior Manager level opportunities throughout North America. He can be reached at jwashburn@endevorscientific.com